ETP-46321
ETP-46321 is a potent and orally bioavailable PI3Kα and PI3Kδ inhibitor with Kiapps of 2.3 and 14.2 nM, respectively.
Product Specifications
CAS Number
[1252594-99-2]
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
PI3K
Type
Reference compound
Related Pathways
PI3K/Akt/mTOR
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/etp-46321.html
Purity
99.34
Solubility
DMSO : ≥ 33 mg/mL
Smiles
NC(N=C1)=NC=C1C2=CN3C=C(CN4CCN(S(=O)(C)=O)CC4)N=C3C(N5CCOCC5)=N2
Molecular Formula
C20H27N9O3S
Molecular Weight
473.55
Precautions
H302, H315, H319, H335
References & Citations
[1]Martínez González S, et al. Identification of ETP-46321, a potent and orally bioavailable PI3K α, δ inhibitor. Bioorg Med Chem Lett. 2012 May 15;22 (10) :3460-6.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
PI3Kα; PI3Kβ; PI3Kγ; PI3Kδ
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
339630-01 50 µg
VSIG2 (CTXL, V-set and Immunoglobulin Domain-containing Protein 2, Cortical Thymocyte-like Protein, CT-like Protein, CTH, UNQ2770/PRO7154) (FITC)
Ask
View Details 339630-02 100 µg
VSIG2 (CTXL, V-set and Immunoglobulin Domain-containing Protein 2, Cortical Thymocyte-like Protein, CT-like Protein, CTH, UNQ2770/PRO7154) (FITC)
Ask
View Details